These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22305488)

  • 21. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic estrogen in recurrent postpartum affective disorder.
    Sichel DA; Cohen LS; Robertson LM; Ruttenberg A; Rosenbaum JF
    Biol Psychiatry; 1995 Dec; 38(12):814-8. PubMed ID: 8750040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe non-lethal violence during psychotic illness.
    Yee NY; Large MM; Kemp RI; Nielssen OB
    Aust N Z J Psychiatry; 2011 Jun; 45(6):466-72. PubMed ID: 21563864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous estrogen and urinary incontinence.
    Jackson SL; Fihn SD
    J Urol; 2009 May; 181(5):1989-91. PubMed ID: 19286197
    [No Abstract]   [Full Text] [Related]  

  • 27. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of estriol in therapy of urogenital disorders in postmenopausal women].
    Perepanova TS; Khazan PL
    Urologiia; 2007; (3):102-4, 107. PubMed ID: 17722629
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of osteoporosis with estrogen].
    Mizunuma H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():397-403. PubMed ID: 15035159
    [No Abstract]   [Full Text] [Related]  

  • 30. The risk of breast cancer linked to menopausal hormone therapy.
    Sæther S; Bakken K; Lund E
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1330-4. PubMed ID: 22717857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of urinary incontinence in postmenopausal women].
    Semeniuk AA; Bitiukov NN; Krest'ianinov SS
    Urologiia; 2010; (6):34-6. PubMed ID: 21427991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [First-episode mania with psychotic features induced by over-the-counter diet aids containing sibutramine].
    Binbay T
    Turk Psikiyatri Derg; 2010; 21(4):335-7. PubMed ID: 21125509
    [No Abstract]   [Full Text] [Related]  

  • 33. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
    Baker VL
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recommendations for estrogen and progesterone replacement in climacteric and postmenopause. 33. Workshop of the "Zurich Discussion Circle", October 2004].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):53-7. PubMed ID: 16452821
    [No Abstract]   [Full Text] [Related]  

  • 35. Estrogen replacement therapy may reduce panic symptoms.
    Chung CK; Remington ND; Suh BY
    J Clin Psychiatry; 1995 Nov; 56(11):533. PubMed ID: 7592508
    [No Abstract]   [Full Text] [Related]  

  • 36. Can oestrogen use prevent the onset of psychosis?
    Dhillon R; Bastiampillai T; Mohan T; Khor L
    Aust N Z J Psychiatry; 2013 Jul; 47(7):682-3. PubMed ID: 23439316
    [No Abstract]   [Full Text] [Related]  

  • 37. Post-ovariectomy and oestrogen therapy related recurrence of oestrogen withdrawal associated psychosis.
    Chandra PS
    Acta Psychiatr Scand; 2002 Jul; 106(1):76; author reply 76-7. PubMed ID: 12100352
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study.
    Stevenson JC; Durand G; Kahler E; Pertyński T
    Maturitas; 2010 Nov; 67(3):227-32. PubMed ID: 20688442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
    Fait T; Vrablik M; Zizka Z; Kostirova M
    Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.